BRAF mutation testing of MSI CRCs in Lynch syndrome diagnostics: performance and efficiency according to patient’s age
Hendrik Bläker, View ORCID ProfileSaskia Haupt, Monika Morak, Elke Holinski-Feder, Alexander Arnold, David Horst, Julia Sieber-Frank, Florian Seidler, Moritz von Winterfeld, Elizabeth Alwers, Jenny Chang-Claude, Hermann Brenner, Wilfried Roth, Christoph Engel, Markus Löffler, Gabriela Möslein, Hans-Konrad Schackert, Jürgen Weitz, Claudia Perne, Stefan Aretz, Robert Hüneburg, Wolff Schmiegel, Deepak Vangala, Nils Rahner, Verena Steinke-Lange, Vincent Heuveline, Magnus von Knebel Doeberitz, Aysel Ahadova, Michael Hoffmeister, Matthias Kloor, the German Consortium for Familial Intestinal Cancer
doi: https://doi.org/10.1101/19009274
Hendrik Bläker
1Institute of Pathology, University Hospital Leipzig, Leipzig, Germany
Saskia Haupt
2Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany
Monika Morak
3Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany
4MGZ – Medical Genetics Center, Munich, Germany
Elke Holinski-Feder
3Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany
4MGZ – Medical Genetics Center, Munich, Germany
Alexander Arnold
5Institute of Pathology, Charite Berlin, Berlin, Germany
David Horst
5Institute of Pathology, Charite Berlin, Berlin, Germany
Julia Sieber-Frank
6Department of Applied Tumor Biology, University Hospital Heidelberg, Cooperation Unit Applied Tumor Biology, German Cancer research Center (DKFZ), and Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany
Florian Seidler
6Department of Applied Tumor Biology, University Hospital Heidelberg, Cooperation Unit Applied Tumor Biology, German Cancer research Center (DKFZ), and Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany
Moritz von Winterfeld
7Department of General Pathology, Institute of Pathology, University Hospital Heidelberg
Elizabeth Alwers
8Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Germany
Jenny Chang-Claude
9Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Germany
Hermann Brenner
8Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Germany
10Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Germany
11German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
Wilfried Roth
12Institute of Pathology, University Hospital Mainz, Germany
Christoph Engel
13Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
Markus Löffler
13Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
Gabriela Möslein
14Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, Germany
Hans-Konrad Schackert
15Department of Surgery, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
Jürgen Weitz
15Department of Surgery, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
Claudia Perne
16Institute of Human Genetics, University of Bonn, Bonn, Germany
17Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany
Stefan Aretz
16Institute of Human Genetics, University of Bonn, Bonn, Germany
17Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany
Robert Hüneburg
17Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany
Wolff Schmiegel
18Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany
Deepak Vangala
18Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany
Nils Rahner
19Medical Faculty, Institute of Human Genetics, Heinrich-Heine University, Düsseldorf, Germany
Verena Steinke-Lange
3Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany
4MGZ – Medical Genetics Center, Munich, Germany
Vincent Heuveline
2Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany
Magnus von Knebel Doeberitz
6Department of Applied Tumor Biology, University Hospital Heidelberg, Cooperation Unit Applied Tumor Biology, German Cancer research Center (DKFZ), and Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany
Aysel Ahadova
6Department of Applied Tumor Biology, University Hospital Heidelberg, Cooperation Unit Applied Tumor Biology, German Cancer research Center (DKFZ), and Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany
Michael Hoffmeister
8Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Germany
Matthias Kloor
6Department of Applied Tumor Biology, University Hospital Heidelberg, Cooperation Unit Applied Tumor Biology, German Cancer research Center (DKFZ), and Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany
Data Availability
All relevant data are included in the supplementary material.
Posted October 16, 2019.
BRAF mutation testing of MSI CRCs in Lynch syndrome diagnostics: performance and efficiency according to patient’s age
Hendrik Bläker, Saskia Haupt, Monika Morak, Elke Holinski-Feder, Alexander Arnold, David Horst, Julia Sieber-Frank, Florian Seidler, Moritz von Winterfeld, Elizabeth Alwers, Jenny Chang-Claude, Hermann Brenner, Wilfried Roth, Christoph Engel, Markus Löffler, Gabriela Möslein, Hans-Konrad Schackert, Jürgen Weitz, Claudia Perne, Stefan Aretz, Robert Hüneburg, Wolff Schmiegel, Deepak Vangala, Nils Rahner, Verena Steinke-Lange, Vincent Heuveline, Magnus von Knebel Doeberitz, Aysel Ahadova, Michael Hoffmeister, Matthias Kloor, the German Consortium for Familial Intestinal Cancer
medRxiv 19009274; doi: https://doi.org/10.1101/19009274
BRAF mutation testing of MSI CRCs in Lynch syndrome diagnostics: performance and efficiency according to patient’s age
Hendrik Bläker, Saskia Haupt, Monika Morak, Elke Holinski-Feder, Alexander Arnold, David Horst, Julia Sieber-Frank, Florian Seidler, Moritz von Winterfeld, Elizabeth Alwers, Jenny Chang-Claude, Hermann Brenner, Wilfried Roth, Christoph Engel, Markus Löffler, Gabriela Möslein, Hans-Konrad Schackert, Jürgen Weitz, Claudia Perne, Stefan Aretz, Robert Hüneburg, Wolff Schmiegel, Deepak Vangala, Nils Rahner, Verena Steinke-Lange, Vincent Heuveline, Magnus von Knebel Doeberitz, Aysel Ahadova, Michael Hoffmeister, Matthias Kloor, the German Consortium for Familial Intestinal Cancer
medRxiv 19009274; doi: https://doi.org/10.1101/19009274
Subject Area
Subject Areas
- Addiction Medicine (393)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2882)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12622)
- Forensic Medicine (10)
- Gastroenterology (813)
- Genetic and Genomic Medicine (4483)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (911)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4251)
- Nursing (228)
- Nutrition (622)
- Oncology (2226)
- Ophthalmology (634)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1182)
- Primary Care Research (488)
- Public and Global Health (6829)
- Radiology and Imaging (1503)
- Respiratory Medicine (909)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)